Potential anti-diabetic applications of a new molecule with affinity for β3-Adrenoceptors

This publication has 12 references indexed in Scilit:

• Desensitization effect of in vivo treatment with metaproterenol on β1, β2 and β3-adrenergic responsiveness in rat adipocytes
  Life Sciences, 1995
• Inotropic and Chronotropic Effects of 4-(4′-n-Butylaniline)-7,8-dimethoxy-5H-pyrimido[5,4–b]indole in Guinea-pig Atria
  Journal of Pharmacy and Pharmacology, 1995
• Distribution of β3-adrenoceptor mRNA in human tissues
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Anti-obesity and anti-diabetic effects of CL 316, 243, a highly specific β3-adrenoceptor agonist, in yellow KK mice
  Life Sciences, 1994
• The β‐adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the β3‐, but also of the β₂‐subtype
  British Journal of Pharmacology, 1993
• Correlation of β3-adrenoceptor-induced activation of cyclic amp-dependent protein kinase with activation of lipolysis in rat white adipocytes
  Biochemical Pharmacology, 1993
• Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus
  British Journal of Pharmacology, 1993
• Effects of a .BETA.3-Adrenoceptor Agonist, BRL 26830A, on Insulin and Glucagon Release in Mice.
  Endocrinologia Japonica, 1991
• Molecular Characterization of the Human β ₃ -Adrenergic Receptor
  Science, 1989
• Effects of BRL 26830, a novel β-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in zucker (fa/fa) rats
  Biochemical Pharmacology, 1985